Related Experiment Video

Updated: Aug 9, 2026

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
12:50

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

Alzheimer's disease and vascular dementia. Some points of confluence

H Agüero-Torres1, B Winblad

  • 1Stockholm Gerontology Research Center, Karolinska Institute, Sweden. Hedda.Aguero-Eklund@neurotec.ki.se

Annals of the New York Academy of Sciences
|May 20, 2000
PubMed

Insights

The distinction between Alzheimer's disease and vascular dementia is blurring due to a lack of biomarkers and overlapping risk factors. Research suggests both vascular and degenerative processes contribute to dementia, especially in older adults.

Area of Science:

  • Neurology
  • Gerontology
  • Pathology

Background:

  • Traditional differentiation between Alzheimer's disease (AD) and vascular dementia (VaD) is challenged by the absence of specific biomarkers.
  • Controversy exists regarding the precise definition and diagnostic criteria for vascular dementia.
  • Emerging evidence highlights the role of vascular risk factors in the pathogenesis of Alzheimer's disease.

Purpose of the Study:

  • To address the diminishing clarity in differentiating Alzheimer's disease from vascular dementia.
  • To explore the combined contribution of vascular and degenerative mechanisms in dementia development, particularly in the elderly.
  • To investigate the relationship between vascular and degenerative pathologies in dementia: are they parallel or interacting processes?

Main Methods:

  • Review of existing literature on Alzheimer's disease and vascular dementia.
  • Analysis of current diagnostic criteria and biomarker research.
  • Consideration of epidemiological data on vascular risk factors and dementia.

Main Results:

  • The traditional separation of AD and VaD is increasingly unclear.
  • Both vascular and degenerative mechanisms are implicated in dementia, especially in advanced age.
  • The precise interplay between vascular and degenerative pathologies requires further elucidation.

Conclusions:

  • The traditional dichotomy between Alzheimer's disease and vascular dementia is no longer tenable.
  • Dementia, particularly in the elderly, likely results from a complex interplay of vascular and degenerative factors.
  • Future research must clarify whether these pathologies represent independent processes or interact synergistically.

More Related Videos

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke09:45

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke

Published on: March 22, 2016

Using Retinal Imaging to Study Dementia09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...